AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30323359
Drug: 24IU intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24IU intranasal oxytocin
Trial: 22889586
Drug: 48IU intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 48IU intranasal oxytocin
Trial: 1955002
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP)
Trial: 2268518
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate tablets at a dose of 1 g twice daily
Trial: 26927445
Drug: Sodium-glucose co-transporter-2
RxNorm normalized name: CO
DrugBank: Carbon monoxide (DB11588)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium-glucose co-transporter-2 inhibitors
Trial: 20576732
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 μg once daily (Tio)
Trial: 16814402
Drug: Pain relievers
RxNorm normalized name: LidoPro Pain Relieving Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain relievers (opioids, paracetamol, diclofenac)
Trial: 8706194
Drug: Sublingual triazolam
RxNorm normalized name: Triazolam
DrugBank: Triazolam (DB00897)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual triazolam 0.2 mg (T)
Trial: 8706194
Drug: Peroral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peroral diazepam 10 mg (D)
Trial: 2082487
Drug: Dipyridamole 100
RxNorm normalized name: dipyridamole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole 100 mg q.i.d. starting 2 days before surgery, followed by aspirin 325 mg t.i.d. plus dipyridamole 75 mg t.i.d. 7 hours after surgery
Trial: 2082487
Drug: Antiplatelet regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet regimen (dipyridamole and aspirin)
Trial: 346168
Drug: Base alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Base alone applied four times daily for one week
Trial: 27838323
Drug: Grass SLIT-tablet
RxNorm normalized name: Timothy grass pollen extract Sublingual Tablet [Grastek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grass SLIT-tablet (MK-7243; ≤2800 bioequivalent allergen units/75,000 SQ-T dose)
Trial: 27838323
Drug: Short ragweed
RxNorm normalized name: weed pollen-short ragweed
DrugBank: Ambrosia artemisiifolia pollen (DB10385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short ragweed SLIT-tablet (MK-3641; ≤12 Amb a 1-U)
Trial: 27838323
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite SLIT-tablet (MK-8237; ≤12 SQ-HDM)
Trial: 27838323
Drug: Placebo (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (for all SLIT-tablet trials)
Trial: 31613323
Drug: Ongoing anticholinergic
RxNorm normalized name: Ongo-Fin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing anticholinergic medication
Trial: 27452270
Drug: OFD +
RxNorm normalized name: OFDZ
DrugBank: Oxfendazole (DB11446)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OFD + PRF + 1.2% RSV gel
Trial: 23113643
Drug: fermented bilberry
RxNorm normalized name: Bilberry
DrugBank: Bilberry (DB14235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fermented bilberry extract (400 mg/day)
Trial: 9249109
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl infusion (Group III)
Trial: 9249109
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (Group II)
Trial: 27451347
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids and severity-specific inhaled bronchodilator therapy
Trial: 15923168
Drug: Chemotherapy for
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy for multiple myeloma
Trial: 8522640
Drug: Ro 41-3696
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 41-3696 at doses of 10 mg and 30 mg
Trial: 17522399
Drug: Advanced life
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced life support (ALS) treatment, including endotracheal intubation and intravenous drugs, administered to 56.6% of patients during the second phase.
Trial: 17522399
Drug: Intravenous drugs
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous drugs administered to 15.0% of patients during the second phase.
Trial: 17522399
Drug: Use of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Use of nebulized salbutamol and sublingual nitroglycerin increased during the second phase.
Trial: 14742379
Drug: memantine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: memantine (30 mg/d)
Trial: 11167376
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with polyurethane-coated cotton encasings for bedding
Trial: 9459625
Drug: Cytokine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine treatment (interferon-alpha or interferon-beta, either alone or in combination with interleukin-2 or antineoplastic agents)
Trial: 7949265
Drug: CDCA (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CDCA (15 mg/kg/day for 15-20 days)
Trial: 2851180
Drug: Cisplatin (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (120 mg/m2 on day 1)
Trial: 7911677
Drug: Pre- and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre- and postoperative chemotherapy (5-drug-combination + tamoxifen)
Trial: 31373827
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment + observation)
Trial: 22673924
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg daily)
Trial: 22673924
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 U daily)
Trial: 28624580
Drug: PPI (pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI (pantoprazole 40 mg/day)
Trial: 15206014
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of a second opioid at low doses (initial equivalent dosage of 20% of previous therapy)
Trial: 15206014
Drug: Addition of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addition of a second opioid at low doses
Trial: 2512104
Drug: Phenobarbital administered
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital administered by primary health care workers trained by a three-day course in community 'A'
Trial: 2512104
Drug: Phenobarbital administered
RxNorm normalized name: Phenobarbital
DrugBank: Phenobarbital (DB01174)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbital administered by neurologists in community 'B'
Trial: 28685353
Drug: Peginterferon beta-1a
RxNorm normalized name: Peginterferon Beta-1A
DrugBank: Peginterferon beta-1a (DB09122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon beta-1a 125 mcg
Trial: 25381447
Drug: Monolingual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monolingual treatment
Trial: 16019861
Drug: Local hyperthermia
RxNorm normalized name: docusate calcium / phenolphthalein Oral Capsule [Docal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local hyperthermia treatment (Group A)
Trial: 10522998
Drug: 3.75 mg
RxNorm normalized name: zopiclone 3.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.75 mg triptorelin im every 4 weeks for 2 years (n = 20)
Trial: 7851581
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n = 10)
Trial: 7295489
Drug: Diacetolol 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diacetolol 200 mg
Trial: 26746199
Drug: Home-care F(−)
RxNorm normalized name: Gelato Home-Care 1.1 % Toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-care F(−) treatment (FD) - 1,100 ppm F(−) dentifrice, 2x1 min/day
Trial: 26746199
Drug: Professional fluoride
RxNorm normalized name: Clearskin Professional Daily Correcting
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional fluoride treatment (FVD) - 22,600 ppm F(−) varnish plus FD
Trial: 11099368
Drug: Whole food
RxNorm normalized name: Concentrated Whole Food Multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole food (WF: protein 38 g; carbohydrate 70 g; fat 7 g)
Trial: 24219166
Drug: Buprenorphine-naloxone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine-naloxone treatment for 12 weeks
Trial: 18053393
Drug: Beta-blockers (atenolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (atenolol 100 mg id for five consecutive days)
Trial: 16075416
Drug: Simvastatin and
RxNorm normalized name: simvastatin and ezetimibe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin and Atorvastatin
Trial: 10229887
Drug: Peer Assessment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer Assessment Rating (PAR) index treatment
Trial: 8561152
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (tetracycline 250 mg, metronidazole 250 mg, colloidal bismuth subcitrate 120 mg, four times daily for 14 days)
Trial: 8561152
Drug: Amoxicillin (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (1000 mg) and omeprazole (40 mg) both twice daily for 14 days
Trial: 8561152
Drug: Amoxicillin/omeprazole
RxNorm normalized name: AMOXICILLIN/OMEPRAZOLE/RIFABUTIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/omeprazole
Trial: 6882885
Drug: Quinidine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine administered with antacid
Trial: 6882885
Drug: Quinidine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinidine administered in fasting state
Trial: 30869165
Drug: Perampanel 12
RxNorm normalized name: perampanel 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perampanel 12 mg
Trial: 17371337
Drug: Doxazosin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (4 mg/day)
Trial: 20368567
Drug: Rituximab added
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab added to cyclophosphamide, doxorubicin, vincristine, and prednisone induction treatment
Trial: 20368567
Drug: BCL2/IgH levels
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCL2/IgH levels at the end of induction treatment
Trial: 9735662
Drug: Specific IgG
RxNorm normalized name: Mold specific IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgG antibodies
Trial: 9735662
Drug: Specific IgG4
RxNorm normalized name: PACIFIC OYSTER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgG4 antibodies
Trial: 1099048
Drug: Doctor's Choice
RxNorm normalized name: Doctor's Choice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doctor's Choice (DC) method of administering psychotropic drugs
Trial: 1099048
Drug: Thioridazine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thioridazine (100 to 900 mg)
Trial: 1099048
Drug: Chlordiazepoxide (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlordiazepoxide (30 mg)
Trial: 3088636
Drug: Imipramine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (75 mg)
Trial: 29034602
Drug: Paracetamol alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol alone (G-1)
Trial: 20821332
Drug: Conservative standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative standard treatment (CST)
Trial: 16315646
Drug: Complete case
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete case analysis (CC)
Trial: 1776351
Drug: Aqueous CO2
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous CO2 (succinate + sodium bicarbonate = Kao Bub; 1400 mg CO2 per kg water)
Trial: 31899024
Drug: Topical Oxymetazoline
RxNorm normalized name: oxymetazoline Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Oxymetazoline
Trial: 30732134
Drug: Tobramycin/dexamethasone ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobramycin/dexamethasone ointment
Trial: 18162137
Drug: 500 mcg
RxNorm normalized name: Nplate 500 MCG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mcg fluticasone propionate twice daily
Trial: 12418594
Drug: 5 days
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 days of oral prednisolone (40 mg daily)
Trial: 2137901
Drug: 6 g
RxNorm normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 g per day of 85 percent eicosapentaenoic and docosahexaenoic acids
Trial: 24994571
Drug: SVV-based goal-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SVV-based goal-directed therapy (GDT)
Trial: 20837684
Drug: Topical salicylic
RxNorm normalized name: salicylic acid Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical salicylic acid self-application daily
Trial: 28633147
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA) - 2 doses of 15 mg/kg intravenous TXA dissolved in 100 mL of saline, administered over 10 minutes; 1 dose before incision, 1 dose at wound closure.
Trial: 28633147
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - 100 mL of saline solution administered in a similar fashion to TXA.
Trial: 25298165
Drug: Linagliptin and
RxNorm normalized name: linagliptin and empagliflozin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linagliptin and metformin combination therapy
Trial: 21777700
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant (OAC)
Trial: 9296318
Drug: Omeprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (40 mg, twice daily for 5 days)
Trial: 16963663
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (subcutaneous administration)
Trial: 12792378
Drug: cp‐45 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cp‐45 vaccine
Trial: 6281704
Drug: Intravenous Premarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Premarin
Trial: 11402636
Drug: Community pharmacy-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community pharmacy-based intervention including education on disease, pharmacotherapy, and self-management; inhalation technique assessment and correction.
Trial: 9669459
Drug: X‐MS dragees
FDA approved: no
EMA approved: no
PMDA approved: no
Description: X‐MS dragees (8 g X per day)
Trial: 2658606
Drug: Weekly cervical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly cervical examinations and instruction regarding subtle symptoms and signs of preterm labor
Trial: 11803730
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg/day
Trial: 21163939
Drug: Inhaled budesonide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide, 800 μg twice daily for 1 year
Trial: 2412071
Drug: Ketanserin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin, 40 mg b.i.d. for 8 weeks
Trial: 30517252
Drug: 1,600 mg
RxNorm normalized name: omega-3/dha/epa/fish oil 1,600 mg-500 mg-800 mg/5 mL ORAL LIQUID (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,600 mg of oral magnesium hydroxide through nasogastric (NG) tube prior to surgery
Trial: 25733000
Drug: 6.0 mg
RxNorm normalized name: Dimethicone 6.0 mg in 30 mL TOPICAL CREAM [Clapiel Revital Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.0 mg pegfilgrastim
Trial: 26423618
Drug: 6.0 mg
RxNorm normalized name: Dimethicone 6.0 mg in 30 mL TOPICAL CREAM [Clapiel Revital Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.0 mg pegteograstim
Trial: 22674719
Drug: TEA +
RxNorm normalized name: Triethanolamine
DrugBank: Trolamine (DB13747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TEA + l‐NAME
Trial: 20570110
Drug: Amisulpride (200-1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (200-1000 mg) plus Celecoxib (400 mg)
Trial: 20570110
Drug: Amisulpride (200-1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amisulpride (200-1000 mg) plus Placebo
Trial: 12205570
Drug: High-dose salmeterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose salmeterol (100 mcg, BID)
Trial: 12205570
Drug: Albuterol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (2.5 mg, BID)
Trial: 2358610
Drug: Diltiazem (270
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (270 mg/day)
Trial: 17897926
Drug: Verapamil (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (240 mg/day)
Trial: 7178
Drug: Bromazepam 6
RxNorm normalized name: bromazepam 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepam 6 mg t.i.d. during two weeks
Trial: 15227625
Drug: High-dose alanyl-glutamine
RxNorm normalized name: Alanyl glutamine
DrugBank: Alanyl glutamine (DB11876)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose alanyl-glutamine
Trial: 8339412
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of bamiphylline (5 mg/kg in 15 minutes)
Trial: 25079049
Drug: Sonothrombolysis (transcranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonothrombolysis (transcranial Doppler monitoring plus intravenous tissue plasminogen activator)
Trial: 24207098
Drug: Intravenous tissue
RxNorm normalized name: allogeneic processed thymus tissue Drug Implant [Rethymic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tissue plasminogen activator alone
Trial: 23156967
Drug: Low level
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low level laser therapy with energy dose of 52.5 J/cm2 (G-I)
Trial: 10486696
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg/day for 4 weeks
Trial: 8759578
Drug: IV ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ketorolac 60 mg
Trial: 8759578
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IV ketorolac 60 mg and meperidine 50 mg
Trial: 8759578
Drug: IV meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV meperidine 50 mg
Trial: 1747501
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg once a day)
Trial: 1747501
Drug: Ranitidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (300 mg once a day)
Trial: 31792640
Drug: Dotinurad 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dotinurad 0.5 mg
Trial: 31754882
Drug: Dotinurad 1
RxNorm normalized name: Dotinurad
DrugBank: Dotinurad (DB16145)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Dotinurad 1 mg
Trial: 30806926
Drug: RC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RC treatment
Trial: 23812093
Drug: Physiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy treatment program (9 sessions)
Trial: 21558576
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) solution 140 mg/kg
Trial: 21558576
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 140 mg/kg
Trial: 21558576
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) capsules (low doses)
Trial: 11303007
Drug: Omacor 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omacor 2 g twice a day
Trial: 19969286
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Treatment (CBT)
Trial: 16826026
Drug: L-carnitine L-tartrate
RxNorm normalized name: L-carnitine (free form) (as L-carnitine L-tartrate)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine L-tartrate (LCLT) supplementation (2 g of L-carnitine per day)
Trial: 1483879
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg epinephrine added to anesthetic solution
Trial: 24336297
Drug: Triamcinolone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triamcinolone (8 mg, single injection followed by two sham interventions)
Trial: 22314524
Drug: Vancomycin 1
RxNorm normalized name: vancomycin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin 1 g plus Aztreonam 1 g (V/A) q12h
Trial: 17987533
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy of bladder cancer